530825 — Daikaffil Chemicals India Income Statement
0.000.00%
- IN₹1.04bn
- IN₹968.46m
Annual income statement for Daikaffil Chemicals India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 157 | 114 | 81.6 | 6.37 | 0 |
Cost of Revenue | |||||
Gross Profit | 67 | 42.1 | 23 | 1.33 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 150 | 124 | 113 | 31.2 | 26 |
Operating Profit | 7.16 | -9.53 | -31.6 | -24.8 | -26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15 | -4.51 | -27.3 | -20.7 | -18.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.8 | -4.05 | -25 | -21.3 | -19 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.8 | -4.05 | -25 | -21.3 | -19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.8 | -4.05 | -25 | -21.3 | -19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.8 | -0.675 | -4.17 | -3.56 | -3.17 |
Dividends per Share |